1 Min Read
Sept 20 (Reuters) - PHARMALUNDENSIS AB:
* PATENT GRANTED IN EUROPE UNTIL 2032 WITH POSSIBLE EXTENSION FOR 5 YEARS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.